Breaking News

You are here » Indian-Commodity  :  Corporate  :  Union Bank of India reports 11% rise in Q1 net profit

11-Aug2018

Union Bank of India reports 11% rise in Q1 net profit

Union Bank of India has reported results for first quarter ended June 30, 2018.

The Bank has reported 11.12% rise in its net profit at Rs 129.54 crore for the quarter under review as compared to Rs 116.58 crore for the same quarter in the previous year. Total income of the Bank increased by 3.56% at Rs 9,908.76 crore for Q1FY19 as compared Rs 9,567.69 crore for the corresponding quarter previous year.

The Bank's gross NPA for the April-June quarter of the current fiscal increased to 16.00%, as compared to 12.63% in the same quarter of the previous year. Besides, Bank's Net NPA stood at 8.70% in Q1FY19.


Related News

View all news

Bhansali Engineering Polymers reports 33% fall in Q2 net profit

Bhansali Engineering Polymers has reported results for second quarter ended September 30, 2018.The company has reported 32.71% fall in its net profit at Rs 16.89 crore for the quarter under review as compared......

Biocon, Mylan N.V. receive positive CHMP opinion for Ogivri

Biocon and Mylan N.V. have announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval of Ogivri, a biosimilar......

Lupin Neurosciences receives positive CHMP opinion for NaMuscla

Lupin Neurosciences, a specialty pharma division of Lupin has announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMA),......

Top News

View all news

Bhansali Engineering Polymers reports 33% fall in Q2 net profit

Bhansali Engineering Polymers has reported results for second quarter ended September 30, 2018.The company has reported 32.71% fall in its net profit at Rs 16.89 crore for the quarter under review as compared......

Biocon, Mylan N.V. receive positive CHMP opinion for Ogivri

Biocon and Mylan N.V. have announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval of Ogivri, a biosimilar......

Lupin Neurosciences receives positive CHMP opinion for NaMuscla

Lupin Neurosciences, a specialty pharma division of Lupin has announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMA),......